A Comparison of the Effects of Ipratropium Bromide and Metaproterenol Sulfate in Acute Exacerbations of COPD
- 1 October 1990
- Vol. 98 (4) , 835-839
- https://doi.org/10.1378/chest.98.4.835
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfateJournal of Allergy and Clinical Immunology, 1989
- Ipratropium BromideNew England Journal of Medicine, 1988
- Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency roomThe American Journal of Medicine, 1987
- Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center studyThe American Journal of Medicine, 1986
- A Comparison of the Bronchodilating Effects of a Beta-2 Adrenergic Agent (Albuterol) and an Anticholinergic Agent (Ipratropium Bromide), Given by Aerosol Alone or in SequenceNew England Journal of Medicine, 1986
- Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema.Thorax, 1982
- The Effect of Atropine Inhalation in “Irreversible” Chronic BronchitisChest, 1980
- A comparison of ipratropium bromide, deptropine citrate and placebo in asthma and chronic bronchitisRespiratory Medicine, 1977
- Comparative Trial of a New Anticholinergic Bronchodilator, Sch 1000, and Salbutamol in Chronic BronchitisBMJ, 1973
- Variation of Drug Action on Airway Obstruction in ManThorax, 1964